Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study.
Gilmar GutierrezJoshua Daniel RosenblatEmily HawkenJennifer SwainsonGustavo H VázquezPublished in: JMIR research protocols (2022)
DERR1-10.2196/34711.